In the wake of the March 17 passage of S. 483, the Ensuring Patient Access and Effective Drug Enforcement Act of 2016, NACDS is proactively advocating for House passage of legislation that would promote collaboration among government agencies and healthcare stakeholders to ensure patients have access to legitimately needed drugs, while also preventing diversion and abuse of prescription drugs.
The House of Representatives passed its similar version of the legislation, H.R. 471, in April 2015. In order to be signed into law, the House and Senate will need to pass identical language either as a stand-alone bill or as a larger piece of legislation. NACDS is hopeful the House will act soon to approve the legislation.